3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
CVS Health (CVS) earnings Q1 2026
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24,…
Weight-Loss Drugs Like Ozempic May Come With an Unexpected Cost
Glucagon-like peptide-1 (GLP-1) medications are drugs used to treat type 2 diabetes and support weight loss. They mimic…
Pfizer (PFE) earnings Q1 2026
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…
UnitedHealth, Cigna, Humana earnings show insurers are recovering
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to…
Popular Weight-Loss Drugs Found To Cut Heart Attack and Stroke Risk
GLP-1 receptor agonists are showing evidence of sustained cardiovascular effects beyond their established metabolic benefits. Long-term trial data…
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But…
FDA proposes excluding Novo, Lilly GLP-1s from compounding list
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed…
Eli Lilly (LLY) earnings Q1 2026
Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year sales…
Novartis CEO: Reality of Trump’s drug pricing to set in over next 18 months
Vas Narasimhan, chief executive officer of Novartis AG, during an announcement in the Roosevelt Room of the White…
New blood filtering treatment safely extends pregnancy in severe preeclampsia
Cedars-Sinai Health Sciences University investigators have developed and successfully tested a new treatment for pregnant women with severe…
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
Kelonia’s lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for…